A Case of Multidrug-Resistant Tuberculosis in a Young Patient With Rheumatoid Arthritis
Private Practice Infectious Disease · 2024
DOI: 10.55636/ppid04030007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Private Practice Infectious Disease, 2024. Verfasst von Malika Gill und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB) represent a critical global health challenge. MDR TB is characterized by resistance to isoniazid and rifampin, two key first-line anti-TB drugs [1]. XDR TB is characterized by its resistance to isoniazid, rifampin, any fluoroquinolone, and at least one injectable drug, rendering it impervious to most first- and second-line treatment options [1]. Below, we present a case of a patient with a history of rheumatoid arthritis (RA) who was diagnosed with pulmonary TB and was found to have MDR TB.
Zitieren
APA
Gill, M., Adochio, E., & Forrest, G. (2024). A Case of Multidrug-Resistant Tuberculosis in a Young Patient With Rheumatoid Arthritis. Private Practice Infectious Disease. https://doi.org/10.55636/ppid04030007
Vancouver
Gill M, Adochio E, Forrest G. A Case of Multidrug-Resistant Tuberculosis in a Young Patient With Rheumatoid Arthritis. Private Practice Infectious Disease. 2024. doi:10.55636/ppid04030007
BibTeX
@article{Gill2024,
author = {Gill, Malika and Adochio, Emily and Forrest, Graeme},
title = {A Case of Multidrug-Resistant Tuberculosis in a Young Patient With Rheumatoid Arthritis},
journal = {Private Practice Infectious Disease},
year = {2024},
doi = {10.55636/ppid04030007}
}
EUVIMED